These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6135915)

  • 1. Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis.
    Manifold IH; Triger DR; Underwood JC
    Lancet; 1983 Aug; 2(8347):431-3. PubMed ID: 6135915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Kupffer cells in the pathogenesis of liver disease.
    Kolios G; Valatas V; Kouroumalis E
    World J Gastroenterol; 2006 Dec; 12(46):7413-20. PubMed ID: 17167827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages in the Aging Liver and Age-Related Liver Disease.
    Stahl EC; Haschak MJ; Popovic B; Brown BN
    Front Immunol; 2018; 9():2795. PubMed ID: 30555477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Macrophage Diversity in Health and Disease.
    Horn P; Tacke F
    Results Probl Cell Differ; 2024; 74():175-209. PubMed ID: 39406906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers.
    Tsujimoto T; Kuriyama S; Yamazaki M; Nakatani Y; Okuda H; Yoshiji H; Fukui H
    Int J Oncol; 2001 Jan; 18(1):41-7. PubMed ID: 11115537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new view of the roles of blood flow dynamics and Kupffer cell in intra-hepatic metastasis of hepatocellular carcinoma.
    Liu Q; Zhang A; Xu W; Dong J
    Med Hypotheses; 2011 Jul; 77(1):87-90. PubMed ID: 21489701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.
    van der Heide D; Weiskirchen R; Bansal R
    Front Immunol; 2019; 10():2852. PubMed ID: 31849997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis/hepatocellular carcinoma and OPN/Eta-1].
    Uede T; Morimoto J; Kon S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():74-8. PubMed ID: 15453290
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.
    Rode A; Nicoll A; Møller HJ; Lim L; Angus PW; Kronborg I; Arachchi N; Gorelik A; Liew D; Kazankov K; Vilstrup H; Grønbæk H
    Gut; 2013 Aug; 62(8):1231-2. PubMed ID: 23442440
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental study of the development of liver cell carcinoma. Role of histamine in chronic liver injury.
    Ishii K; Suzuki O; Kiryu Y; Tsuchiya M
    Keio J Med; 1975 Jan; 24(1):39-47. PubMed ID: 164577
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of hepatic macrophages in liver metastasis.
    Keirsse J; Van Damme H; Geeraerts X; Beschin A; Raes G; Van Ginderachter JA
    Cell Immunol; 2018 Aug; 330():202-215. PubMed ID: 29661474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary liver cell cancer in autoimmune chronic liver disease.
    Burroughs AK; Bassendine MF; Thomas HC; Sherlock S
    Br Med J (Clin Res Ed); 1981 Jan; 282(6260):273. PubMed ID: 6257324
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of Kupffer cells in hepatic diseases.
    Li P; He K; Li J; Liu Z; Gong J
    Mol Immunol; 2017 May; 85():222-229. PubMed ID: 28314211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma (an approach to the study of risk factors in human cancer).
    London WT
    Ric Clin Lab; 1978; 8(4):232-6. PubMed ID: 216070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NK, NKT cells and macrophages in liver transplantation.
    Fahrner R; Dondorf F; Ardelt M; Settmacher U; Rauchfuss F
    World J Gastroenterol; 2016 Jul; 22(27):6135-44. PubMed ID: 27468206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice.
    Kong L; Zhou Y; Bu H; Lv T; Shi Y; Yang J
    J Exp Clin Cancer Res; 2016 Sep; 35(1):131. PubMed ID: 27589954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma].
    Akahane Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():474-7. PubMed ID: 11761996
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperglobulinaemia in liver disease.
    Triger DR; Wright R
    Lancet; 1973 Jun; 1(7818):1494-6. PubMed ID: 4123153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.